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ABSTRACT
 
Sickle cell anemia (SCA) is a genetic condition caused by 
defective hemoglobin molecules. The in vitro antisickling 
effects of different concentrations of ethanol extracts of 
Annona muricata, Senna alata and Delonix Regia on 
homozygous sickle cell erythrocyte was investigated. 
Standard antisickling tests evaluated include: Osmotic 
fragility, antioxidants (Superoxide dismutase, catalase 
and Glutathione), and polymerization of the sickled red 
blood cell. The experiment was in five groups Group 1 
(Normal RBC), Group 2 (Sickle RBC – experimental 
control group), Group 3 (Sickle RBC + A. muricata), 
Group 4 (Sickle RBC + S. alata) and Group 5 (Sickle 
RBC + D. Regia). Fresh blood was collected from a 
sickle cell patient and normal individual which were used 
for the study. Results obtained from these investigations 
show that the three extracts significantly (p<0.05) 
increased glutathione and catalase activities in the 
sickled red blood cells. A. muricata and S. alata exhibited 
a significant (p<0.05) decrease against superoxide 
dismutase activity while SOD activity in sickle RBC 
treated with D. regia was not significant. Results of 
Osmotic fragility test showed an increase in membrane 
stability of sickle blood when the extracts were added. 
Antisickling test showed the ratio at which sickle blood 
cells were reduced with respect to time. The results of this 
study indicate that the extracts have the potential to 
reduce the sickling activity of sickle cell blood. The 
extracts significantly (p<0.05) reduced the 
polymerization of sickle blood cells at a very high 
concentration (0.2mg/100ml) and increased its 
polymerization at low concentration (0.8mg/100ml). In 
conclusion, findings show that ethanol extracts of A. 
muricata, S. alata and D. regia may be helpful in the 
management of patients with sickle cell anemia. 
 
Keywords: Annona muricata, antisickling, delonix regia, 
erythrocyte fragility, membrane-stability, senna alata, 
sickle cell anemia 
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INTRODUCTION 
Sickle cell disease is a group of genetic 
disorders that affects hemoglobin, the 
molecule in red blood cells that delivers 
oxygen to cells throughout the body. 
Sickling decreases the red blood cells 
flexibility leading to sickle cell anemia and 
results in a risk of various [1]. The 
inherited genetic mutation stems from a 
single nucleotide substitution, amino acid 
valine with glutamic acid, in the β-
globulin gene and produces an abnormal 
type of hemoglobin (Hb), namely, 
hemoglobin S (HbS). The HbS results in 
sickle-shaped red blood cells (RBCs), as 
opposed to normal biconcave disks. The 
sickle-shaped RBCs stick to the vascular 
endothelium and block the small and large 
vessels. Once, the vessels become blocked, 
attacks of pain, known as a vaso-occlusive 
crisis, begin [2-4]. Sickle cell disease 
affects millions of people worldwide. It is 
most common among people whose 
ancestors come from Africa; 
Mediterranean countries such as Greece, 
Turkey, and Italy; the Arabian Peninsula; 
India; and Spanish-speaking regions in 
South America, Central America, and parts 
of the Caribbean. Sickle cell disease is the 
most common inherited blood disorder in 
the United States, affecting 70,000 to 
80,000 Americans. The disease is 
estimated to occur in 1 in 500 African 
Americans and 1 in 1,000 to 1,400 
Hispanic American [1]. Nearly, 80% of 
children affected by this anemia die before 
they are five years old if they are not 
followed medically [5]. The most common 
manifestations in sickle cell disease are 
painful vaso-occlusive crises with pain 
especially in the limbs which result from 
obstruction of the microvasculature by 
sickled red blood cells causing ischemia 
and pain, and also hemolytic anemia and 
end organ damage caused by vasculopathy 
and tissue ischemia. Sickle cell anemia has 
no cure but however, treatments can help 
to relieve symptoms and reduce the 
complications. Orthodox (synthetic) 
treatments have been used in the treatment 
of this anemia, for example, the use of 
antibiotics to prevent infections in infants 
diagnosed with sickle cell anemia, gene 
therapy and blood and marrow stem cell 
transplants may offer a cure for small 
fortunate patients. The health care cost of 
the management of sickle cell anemia 
patients is disproportionately high to 
compare to the number of people afflicted 
by the anemia. The individuals affected by 
this disease are mostly below the poverty 
line and unable to afford the high cost of 
treatment [6-9]. Current treatment of sickle 
cell disease involves blood transfusion and 
bone marrow transplant. After early 
diagnosis, the goal is health maintenance 
to prevent complications and medicines 
and treatments to manage complications, 
including chronic pain. Complications can 
include severe infections, seizures, and 
other clinical problems. About 5 percent of 
people who have received such transplants 
have died. Sometimes transplanted cells 
attack the recipient’s organs. This is called 
graft-versus-host [9]. The use of herbal 
remedies is not a strange phenomenon in 
Africa and it has been estimated that 80% 
of Africans (Falodun, 2010) [10] and about 
27 million South Africans are herbal 
remedy users [11]. Traditional medicine 
practitioners in Nigeria use herbal 
medicines to treat numerous health 
conditions such as mental disorder, 
fractures, insomnia and infertility [12]. 
Several studies have dealt with the use of 
medicinal plants to treat Sickle cell disease 
[13-16]. Findings have shown certain 
medicinal plants used to treat Sickle cell 
disease like Garcinia kola, Annona 
senegalensis, Alcornea cordifolia, Fagara 
zanthoxyloides, Eugenia caryophyllata, 
Pterocarpus osun, Morinda lucida, Ceiba 
pentandra, Dacryodes edulis, Piper 
guineensis Allium, sativum, Hymenocardia 
acida, Vigna unguiculata, Bridelia 
ferrugina, Carica papaya and Sorghum 
bicolor and leaves of Terminalia catapa. 
Others include Cajanus cajan seeds, 
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unripe fruit of Carica papaya, leaves of 
Parquetina nigrescens, Citrus sinensis, 
leaves of Persia americana, Ocimum 
basilicum (Lamiaceae) and Zanthoxyllum 
zanthoxyloides [17-23]. These plants have 
been demonstrated to have antisickling 
properties and are been used today for 
managing sickle cell disease. With 
population increase especially in the third 
world countries like Nigeria, there has 
been an increase in the incidence of sickle 
cell disease with a corresponding increase 
in the demand for its management. 
According to the World Health 
Organization (WHO) in 2007 [24], 
alternative strategies in the management of 
sickle cell disease should include the use 
of traditional medicine. Annona muricata, 
Senna alata and Denolix regia are 
medicinal plants used in the treatment of 
various ailments in Nigeria. Due to the 
increasing need for more potent 
therapeutic plants for the treatment of 
sickle cell disease, ethanol extracts of 
these medicinal plants were investigated 
for potential antisickling properties. 
 
MATERIALS AND METHODS 
Plant Extraction 
Aqueous Infusion 
This research project was conducted at the 
Department of Biochemistry, the 
University of Port Harcourt. The leaves of 
S. alata, A. muricata and D. Regia were 
obtained, authenticated and deposited at 
different herbariums as respectively 
described by Onyegeme-Okerenta and 
Anacletus 2017; [25-27]. They were air-
dried at room temperature (29±1°C) for 3 
weeks and then pulverized with the aid of 
Marlex Excellent grinder (Mumbai, India). 
The powdered samples were kept in an 
airtight container until required. About 100 
g of the powdered leaves were macerated 
in 500 mL of aqueous ethanol (70:30) and 
mixed intermittently for 72 h. The vacuum 
pump was used to filter the mixtures. The 
ethanol plant filtrates were dried over a 
water bath at 40
o
C and the resulting 
extracts were kept in the refrigerator at -
4°C. 
 
Blood Samples 
Ethical approval was obtained from the 
department of Biochemistry research 
ethics committee with the reference 
number UPH/BCHREC/2018/001. A total 
of 2.5ml of fresh blood samples were 
collected from each volunteer by 
venipuncture into an EDTA 
anticoagulating bottles and used for the 
experiment. Blood samples were all 
collected at lively stones medical 
diagnostic laboratory, Choba Rivers State, 
Nigeria.  
 
Catalase Activity Assay 
For determination of catalase activity, 
0.2ml of sample (equivalent to 50-100mg 
protein) was added to 50mM of phosphate 
buffer (pH 7.4) containing 100mM (v/v) of 
H2O2 (Sigma, St Louis, USA) in a total of 
1ml. The mixture was incubated for 2min 
at 37°C and the rate of change in 
absorbance at 240nm was recorded, which 
indicated the decomposition of H2O2. 
Activities were calculated using the molar 
extinction coefficient of H2O2 at 240nm, 
43.59L/mol cm. One unit of catalase 
activity equals the amount of protein that 
converts 1mmol H2O2/min. All samples 
were measured in quadruplicates [28].  
 
Superoxide Dismutase Activity Assay 
An aliquot of supernatant from 12000g 
centrifugation of tissues homogenate was 
diluted with distilled water to make a 1:10 
dilution. A 200µl of the diluted sample 
was added to 2.5ml of 0.05M carbonate 
buffer (pH10.2) to equilibrate in the 
spectrophotometer and the reaction started 
by the addition of 0.3ml of freshly 
prepared 0.3mM epinephrine to the 
mixture which was quickly mixed by 
inversion. The reference cuvette contained 
2.5ml buffer, 0.3ml of the substrate 
(epinephrine) and 0.2ml of distilled water. 
The increase in absorbance at 480nm was 
monitored every 30s for 2.5min [29]. 
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Glutathione-S-transferase Activity Assay 
The medium for the estimation was 
prepared and the reaction was allowed to 
run for 60 s each time before the 
absorbance was read against the blank at 
340nm. The absorbance was measured 
using UNICAM spectrophotometer [29]. 
 
Polymerization 
The polymerization inhibition test was 
carried out following the method of [31]. 
The level of polymerization was 
ascertained by increasing absorbance of 
the assay mixture. A portion of 0.1 ml of 
the erythrocyte hemolysate containing 
HbS was introduced into a test tube 
followed by addition of 0.5 ml of 
Phosphate buffered saline (PBS) solution, 
pH = 7.4 {NaCl (9.0 g)/Na2HPO4.2H2O 
(1.71 g)/ NaH2PO4.2H2PO4.2H2O (2.43 g) 
per 1litre of distilled water} and 1.0ml of 
distilled water. The sample was transferred 
into a cuvette and HbS polymerization was 
induced by adding 3.4 ml of 2% sodium 
metabisulphite solution. The change in 
absorbance of the assay mixture was 
recorded at a regular interval of 30 s for 
180 s at λmax= 700 nm. To determine the 
anti-sickling property of the three 
antimalarial drugs, the procedure above 
was repeated by substituting 1.0 ml of 
distilled water with separate 2 mg% of the 
three antimalarial drugs. 
 
In vitro Antisickling Assay 
Evaluation of the ability of the leaf 
extracts to reverse the sickling state of the 
RBCs was performed by a previously 
described procedure [30]. Five groups 
labeled A, B, C, D and E were set up. 
Group A: contained sickle cell untreated 
(control) Group B: sickle cell + A. 
muricata, Group C: sickle cell + S. alata, 
Group D: sickle cell + D. regia Group E: 
sickle cell + Sodium metabisulphite. For 
the assay 100 μL of SS-RBC pre-
incubated with 2% Na2S2O5 was added to 
100 μl of the solution of different extracts. 
Each mixture was incubated at 37°C and 
antisickling activities observed at time 
intervals of 20, 40, and 60mins 
respectively. After incubation, 10 μL of 
the mixture was diluted 100 times. A drop 
of each sample was examined under the oil 
immersion light microscope and both 
sickled cells and total cells were counted 
from five different fields of view across 
the slide. For the experimental control, the 
solution containing the extract was 
replaced by the saline solution. The 
percentage of sickling was calculated 
using the formula: % of sickling = number 
of sickling cells × 100/total cells. 
 
Osmotic Fragility Test 
The osmotic fragility test was carried out 
following a modification of the previously 
described method by [28]. The stock 
solution of sodium chloride was diluted in 
the ratio of 1:10 with distilled water to 
obtain at 1% solution. Nine tubes were 
taken to prepare dilutions. 0.05ml of the 
blood was then to each of the tubes and 
mix immediately by gently inverting 
several times. A sample from a normal 
individual was also run in parallel as a 
control. It was allowed to stand at room 
temperature (18-20
o
C) for 30 minutes. The 
amount of lysis in each tube is determined 
calorimetrically using a green filter, at 
540nm. The first tube in the series serves 
as a blank (0% lysis) as it contains 0.9% 
isotonic saline. The 12
th
 tube containing 
0.1% saline serves as 100% lysis since this 
gives complete lysis. 
 
Statistical Analysis 
Each test was performed in triplicate and 
the results were expressed as mean ± 
standard deviation. Statistical analysis was 
done using t-test. Values were compared 
and regarded significant at p < 0.05. 
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RESULTS 
Table 1: Antioxidant properties of ethanol extracts of A. muricata, D. regia and S. alata. 
 Glutathione (Unit/ml) Catalase (µmol/ml) SOD (Unit/ml) 
Normal RBC 3.53±0.01 3.77±0.01 0.340±02 
Sickle RBC 3.42 0.02a 8.77 02b 0.17 002c 
Sickle RBC + A. muricata 4.73 0.01a 20.31  0.01b 0.110 0.01c 
Sickle RBC + S. alata 5.03 ± 0.01
 a 22.51 ± 0.01 b 0.13 ± 0.01c 
Sickle RBC + D. regia 3.77 ± 0.10
 a 19.50 ± 0.10 b 0.28 ± 0.01 c 
Note: Data are reported in Mean ± Standard Deviation, values with the same superscript 
shows Statistical Significance at p <0.05. 
 
Percentage inhibition of sickling of red 
blood cells by ethanol leaf extracts of A. 
muricata, D. regia and S. alata at various 
time intervals are presented in Fig. 1. The 
results obtained for the three leave extracts 
tested showed that the percentage of 
sickling cells significantly decreased 
(p<0.05) with the increase in time.
 
 
Figure 1: Inhibition of sickling of RBCs by ethanol extracts of A. muricata, D. regia and S. 
alata. 
 
Osmotic fragilogram of ethanol leaf 
extracts of A. muricata, D. regia and S. 
alata on the human Red Blood Cells is 
shown in Fig. 2. Result indicated that 
there was a significant increase (p<0.05) 
in membrane-stability of Sickle RBC 
when ethanol leaf extracts of A. 
muricata, D. regia and S. alata were 
added to the Sickle RBC respectively.
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Figure 2: Osmotic fragilogram of ethanol leaf extracts of A. muricata, D. regia and S. alata 
on the human red blood cells. 
 
Inhibition of Red Blood Cells 
polymerization by ethanol leaf extracts of 
A. muricata, D. regia and S. alata are 
presented in Fig. 3−5 respectively. Results 
obtained, showed that there were increases 
in the delay of polymerization at various 
concentrations (0.5, 1.0 and 2.0mg/100ml) 
of A. muricata, D. regia and S. alata 
ethanol leaf extracts at varied time 
intervals.
 
 
Figure 3: RBCs polymerization inhibition by ethanol extracts of S. alata. 
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Figure 4: RBCs polymerization inhibition by ethanol extracts of A. muricata. 
 
 
Figure 5: RBCs polymerization inhibition by ethanol extracts of D. regia. 
 
DISCUSSION  
Sickle cell anemia is an inherited form of 
anemia in which the red blood cells are not 
healthy enough to carry adequate oxygen 
throughout the body causing constant 
anemia and occlusion of small blood 
vessels leading to excruciating body pains, 
crisis, complications and other 
manifestations which may occur for no 
reason, or there may be a precipitating 
trigger factor [32]. Anti-sickling tests have 
been developed with the aim of controlling 
the symptoms of sickle cell disease and 
limiting the episode of crisis. Anti-sickling 
agents interfere in three different stages, 
the sickle cell gene level, the hemoglobin 
S polymerization level and/or red cell 
membrane level. We have demonstrated 
experimentally, the antisickling properties 
of ethanol extracts of A. muricata, S. alata 
and D. regia by assaying their ability to 
inhibit sickle cell hemoglobin 
polymerization, Osmotic fragility, Gelatin 
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superoxide dismutase) activities. The three 
extracts significantly (p<0.05) increased 
the enzymatic activities of glutathione-S-
transferase and catalase in the sickled red 
blood cells. A. muricata and S. 
alata exhibited a significant (p<0.05) 
decrease against superoxide dismutase 
activity while SOD activity in sickle RBC 
treated with D. regia was not significant. 
This indicates that A. muricata and S. 
alata have a more antioxidant property 
which enhances their ability to reduce 
oxidative stress that contributes to sickle 
cell crisis and possibly exert antisickling 
effect on the sickle red blood cells. These 
enzymatic antioxidants eliminate free 
radicals which are capable of causing 
inflammatory diseases in sickle cell 
patients and also help protect the body 
from oxidative stress during the 
inflammatory process [33]. It is reported 
that plants with more antioxidant property 
have a higher possible antisickling effect, 
[28].  Sickle cell anemic individual is 
prone to oxidative stress and damage when 
they are in crises. Therefore, ethanol 
extracts of these plants can be used to mop 
up the free radicals generated during a 
crisis and so contribute to the effective 
therapeutic management of the disease. 
The nature and mode of interaction 
between biochemical agents and contact 
points of deoxyhemoglobin S molecules in 
addition to erythrocyte membrane 
structural components are crucial 
determining factors in the capability of 
these agents to retard or inhibit 
polymerization of deoxyhemoglobin S 
molecules, alleviate or prevent erythrocyte 
sickling disorder. The present study 
showed that increase in the concentrations 
of ethanol extracts of A. muricata, S. alata 
and D. regia significantly (p<0.05) 
inhibited the polymerization of sickle 
blood cells while a decrease in the 
concentrations of the extracts significantly 
(p<0.05) increased its polymerization. The 
inhibition of polymerization of 
deoxyhemoglobin S molecules occurred in 
a dose-dependent manner and it was an 
obvious reflection of the capability of the 
plant extracts to decrease the rapid rate of 
polymerization of hemoglobin S molecules 
in the blood sample. Studies by Chikezie 
(2011) and Chikezie et al., (2013), [35-36] 
reported that the process of gelation 
(polymerization) of hemoglobin molecules 
increases the formation of sickling cells. 
Also, in vitro deoxygenation of RBC by 
sodium metabisulphite caused progressive 
aggregation and polymerization of the 
individual hemoglobin molecules. 
 
Research into antisickling properties of 
medicinal plants has been rewarding in the 
management of sickle cell anemia. 
Antisickling test showed the ratio at which 
sickle blood cells were reduced with 
respect to time. Percentage inhibition of 
sickling of red blood cells by ethanol leaf 
extracts of A. muricata, D. regia and S. 
alata at various time intervals was 
reported in this study. Results obtained 
showed that the percentage of sickling 
cells significantly decreased (p<0.05) with 
the increase in time. This is an indication 
that the extracts have the potential to 
reduce the sickling activity of sickle cell 
blood by increasing the oxygen affinity of 
the cells. Plant extracts contain bioactive 
constituents that may enhance the 
antisickling efficacy of the extract. The 
presence of such compounds could 
partially explain the pharmacological 
properties of these extracts. An example of 
such phytochemical is phenol which is 
richly present in A. muricata. Studies have 
also suggested the presence of essential 
minerals such as zinc, potassium, calcium, 
sodium, copper, iron and magnesium in A. 
muricata. The action of zinc and 
magnesium in improving the iron ratio is 
likened to reversing the functional state of 
sickle erythrocytes to their original 
biconcave structure, thereby increasing the 
oxygen affinity of the cells [37]. 
 
Studies done on normal red blood cell and 
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sickle red blood cell in the past showed 
that osmotic fragility of normal red blood 
cells is greater than that of sickle red 
blood, due to their biconcave shape which 
allows for more volume of water in a 
hypotonic solution before stretching of the 
membrane leading to hemolysis. Sickle 
erythrocytes have been reported to have a 
distorted volume –to- surface ratio when 
compared to normal erythrocytes [38]. 
Most of the cells supplemented with 
ethanol extracts of A. muricata, S. alata 
and D. regia were still rounded after 
incubating in salt solutions which showed 
that the extracts have induced membrane 
stability on the sickle red blood cell. This 
observed inhibition in RBC lysis after 
treatment with these extracts is indicative 
of protective properties of the extract on 
the RBC membrane, thus helping to 
maintain membrane integrity. 
 
CONCLUSION 
Ethanol extracts of A. muricata, D. regia 
and S. alata have the potentials to reverse 
sickling in human sickle RBCs. This was 
shown in their ability to significantly 
decrease the rate of hemoglobin 
polymerization, the percentage of sickled 
cells, and the osmotic fragility of human 
sickle RBCs. Similarly, they possess 
antioxidant properties which protect the 
red cells from oxidative damage caused by 
free radicals. The inhibitory/reduction 
activities of ethanol extracts of A. 
muricata, D. regia and S. alata could be 
due to the synergistic properties of 
bioactive compounds present in these 
plants. Therefore, it can be concluded that 
they may be used for the therapeutic 
management of sickle cell anemia 
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